International Cannabis Weekly: 439

US CANNABIS RESCHEDULING: A VICTORY OR A FEDERAL TRAP?

US cannabis rescheduling, much like President Donald Trump who is rightly credited for finally pushing it forward, has sucked all the oxygen out of the room for the last two years. The project dominates headlines, largely dictates stock prices, and is a central part of any forward facing cannabis debate. This is understandable. The cannabis industry rarely gets the chance to celebrate regulatory progress on such a scale.

READ MORE  »

POLAND MEDICAL CANNABIS MARKET SHOWS FULL POST-BAN RECOVERY

READ MORE »

US CANNABIS OPERATORS EYE ‘STRUCTURING’ EUROPEAN MARKET OPPORTUNITY

READ MORE »

• France’s medical cannabis framework questioned over whether it prioritises patients or regulators.
• Tighter cannabis regulations will be debated in German Bundestag petitions committee.
• Medical cannabis patient wins two-year legal battle over wrongful driving conviction.
• Curaleaf Laboratories and Sanity Group announce partnership to advance medical cannabis innovation in the UK.
• Bristol Medical School is poised to offer first teaching placement in cannabis medicine.
• European hemp stalwart HempFlax Group departs Romania after 14-year operational run.
• Newly listed Dutch hemp variety shows potential to challenge Europe’s fibre incumbents.
• Bridging the gap: Medical cannabis, regulators, and the reality of clinical accountability.

VIEW REPORT »

• Florida lawmakers are set to vote to reduce medical cannabis fees for military veterans.
• Virginia House amends Senate-passed cannabis sales bill ahead of bicameral negotiations.
• Oregon House passes bill allowing medical cannabis access for hospice patients.
• New Jersey has clarified the rules governing cannabis collectives under state law.
• Michigan cannabis sales have declined sharply at the start of 2026, data has shown.
• Glass House Brands board has established its product expansion committee.
• South Dakota medical cannabis cards are poised to transition to a new digital format.
• Curaleaf closes $500 million private placement of 11.5% senior secured notes.

• MTL Cannabis shareholders have approved the acquisition by Canopy Growth.
• Village Farms has amended and extended Canadian cannabis credit facility.
• Avant Brands has announced the timing for release of its fiscal 2025 annual results.
• Canada’s cannabis market reaches new high in December 2025 as producer price index launches.
• Health Canada has made the move to update its cannabis sampling rules for licensed producers.
• Rubicon Organics has completed its first harvest at its Cascadia cultivation facility, it says.

• Portuguesa pioneers are starting to use of CBD in Brazilian football to aid athlete recovery.
• Medical cannabis remains legal in Brazil as 2026 law framework has been finally clarified.
• Santiago Augusto says export path is safest for Argentina but traceability must be prioritised.
• Uruguay evaluates allowing legal cannabis sales to tourists and non-resident foreigners.

• Organigram has launched 10 new SKUs in the Australian medical cannabis market.
• Australia has decided to tighten the medical cannabis rules affecting veteran access.
• A cancer survivor has called for Fiji to relax hemp and cannabis laws in light of medicinal benefits.
• Vitura Health has made plans for an investor briefing on H1 FY2026 financial results.

• Ghana’s industrial and medicinal cannabis sector presents emerging opportunities and challenges.
• Labour Court rules in favour of officer dismissed for cannabis use, awards R553,000 backpay.